tafluprost
Generic: tafluprost opthalmic
Labeler: micro labs limitedDrug Facts
Product Profile
Brand Name
tafluprost
Generic Name
tafluprost opthalmic
Labeler
micro labs limited
Dosage Form
SOLUTION/ DROPS
Routes
Active Ingredients
tafluprost .0045 mg/.3mL
Manufacturer
Identifiers & Regulatory
Product NDC
42571-264
Product ID
42571-264_4c55f162-175b-d458-e063-6394a90a066f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209051
Listing Expiration
2027-12-31
Marketing Start
2022-11-18
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42571264
Hyphenated Format
42571-264
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tafluprost (source: ndc)
Generic Name
tafluprost opthalmic (source: ndc)
Application Number
ANDA209051 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .0045 mg/.3mL
Packaging
- 1 POUCH in 1 CARTON (42571-264-26) / 15 VIAL in 1 POUCH / .3 mL in 1 VIAL
- 2 POUCH in 1 CARTON (42571-264-73) / 15 VIAL in 1 POUCH / .3 mL in 1 VIAL
- 6 POUCH in 1 CARTON (42571-264-74) / 15 VIAL in 1 POUCH / .3 mL in 1 VIAL
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "4c55f162-175b-d458-e063-6394a90a066f", "openfda": {"nui": ["N0000175454", "N0000000106", "N0000009526", "M0017805"], "upc": ["0342571264734", "0342571264932"], "unii": ["1O6WQ6T7G3"], "rxcui": ["1244611"], "spl_set_id": ["fcaab8b3-3791-49ba-909e-a09651a30b33"], "pharm_class_cs": ["Prostaglandins [CS]"], "pharm_class_pe": ["Increased Prostaglandin Activity [PE]"], "pharm_class_epc": ["Prostaglandin Analog [EPC]"], "pharm_class_moa": ["Prostaglandin Receptor Agonists [MoA]"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (42571-264-26) / 15 VIAL in 1 POUCH / .3 mL in 1 VIAL", "package_ndc": "42571-264-26", "marketing_start_date": "20221118"}, {"sample": false, "description": "2 POUCH in 1 CARTON (42571-264-73) / 15 VIAL in 1 POUCH / .3 mL in 1 VIAL", "package_ndc": "42571-264-73", "marketing_start_date": "20221118"}, {"sample": false, "description": "6 POUCH in 1 CARTON (42571-264-74) / 15 VIAL in 1 POUCH / .3 mL in 1 VIAL", "package_ndc": "42571-264-74", "marketing_start_date": "20221118"}], "brand_name": "tafluprost", "product_id": "42571-264_4c55f162-175b-d458-e063-6394a90a066f", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Increased Prostaglandin Activity [PE]", "Prostaglandin Analog [EPC]", "Prostaglandin Receptor Agonists [MoA]", "Prostaglandins [CS]"], "product_ndc": "42571-264", "generic_name": "tafluprost opthalmic", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tafluprost", "active_ingredients": [{"name": "TAFLUPROST", "strength": ".0045 mg/.3mL"}], "application_number": "ANDA209051", "marketing_category": "ANDA", "marketing_start_date": "20221118", "listing_expiration_date": "20271231"}